FDA Announces Recall of Epinephrine

The U.S. Food and Drug Administration in White Oak, Md., on July 20, 2020. Sarah Silbiger/Getty Images

The U.S. Food and Drug Administration (FDA) announced the recall of three epinephrine lots, used to treat severe allergic reactions, after consumer complaints.

According to an announcement, manufacturer Spectrum Laboratory Products said it voluntarily recalled the lots after the product was found to be discolored.